Antitrust Enforcement in the Health Care Sector to remain a key focus in the Biden Administration
JD Supra: Mergers
DECEMBER 19, 2023
On December 7, 2023, the White House announced a series of initiatives to “lower health care and prescription drug costs by promoting competition.” Citing increasing concentration in the health care industry among payers, providers, and drug companies, the Administration outlined new inter-agency efforts to stop what it views to be “anticompetitive mergers and anticompetitive practices by dominant corporations in health care markets.”.
Let's personalize your content